Healthcare Services Group, Inc. (HCSG)
USD 14.78
(1.79%)
USD 14.78
(1.79%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -10.69 Million USD | -256.86% |
| 2022 | 6.81 Million USD | 111.46% |
| 2021 | -59.49 Million USD | 53.51% |
| 2020 | -127.96 Million USD | -716.12% |
| 2019 | -15.68 Million USD | -494.47% |
| 2018 | 3.97 Million USD | -84.61% |
| 2017 | 25.82 Million USD | 208.27% |
| 2016 | -23.85 Million USD | 28.13% |
| 2015 | -33.18 Million USD | 55.91% |
| 2014 | -75.28 Million USD | -17.34% |
| 2013 | -64.15 Million USD | 6.95% |
| 2012 | -68.94 Million USD | -78.44% |
| 2011 | -38.63 Million USD | 2.65% |
| 2010 | -39.69 Million USD | -26.81% |
| 2009 | -31.3 Million USD | 16.53% |
| 2008 | -37.5 Million USD | 59.44% |
| 2007 | -92.46 Million USD | -26.66% |
| 2006 | -72.99 Million USD | 19.79% |
| 2005 | -91 Million USD | -21.59% |
| 2004 | -74.84 Million USD | -16.62% |
| 2003 | -64.18 Million USD | -32.82% |
| 2002 | -48.32 Million USD | -41.04% |
| 2001 | -34.25 Million USD | -49.99% |
| 2000 | -22.84 Million USD | -32.8% |
| 1999 | -17.2 Million USD | 0.0% |
| 1998 | -17.2 Million USD | 3.37% |
| 1997 | -17.8 Million USD | 21.59% |
| 1996 | -22.7 Million USD | -39.26% |
| 1995 | -16.3 Million USD | -45.54% |
| 1994 | -11.2 Million USD | -41.77% |
| 1993 | -7.9 Million USD | -23.44% |
| 1992 | -6.4 Million USD | 34.69% |
| 1991 | -9.8 Million USD | -34.25% |
| 1990 | -7.3 Million USD | -219.67% |
| 1989 | 6.1 Million USD | 74.29% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | -2.05 Million USD | -37.26% |
| 2024 Q1 | -3.39 Million USD | 68.27% |
| 2024 Q2 | 11.11 Million USD | 427.59% |
| 2023 Q3 | -19.66 Million USD | -15.0% |
| 2023 Q2 | -17.1 Million USD | -126.01% |
| 2023 Q1 | -7.56 Million USD | -210.99% |
| 2023 FY | -10.69 Million USD | -256.86% |
| 2023 Q4 | -10.69 Million USD | 45.62% |
| 2022 FY | 6.81 Million USD | 111.46% |
| 2022 Q1 | -12.31 Million USD | 79.31% |
| 2022 Q2 | -11.82 Million USD | 3.95% |
| 2022 Q3 | 14.11 Million USD | 219.37% |
| 2022 Q4 | 6.81 Million USD | -51.7% |
| 2021 FY | -59.49 Million USD | 53.51% |
| 2021 Q4 | -59.49 Million USD | 12.23% |
| 2021 Q3 | -67.78 Million USD | 39.98% |
| 2021 Q1 | -111.38 Million USD | 12.96% |
| 2021 Q2 | -112.93 Million USD | -1.4% |
| 2020 Q2 | -66.02 Million USD | -26.36% |
| 2020 FY | -127.96 Million USD | -716.12% |
| 2020 Q4 | -127.96 Million USD | -30.21% |
| 2020 Q3 | -98.28 Million USD | -48.85% |
| 2020 Q1 | -52.25 Million USD | -233.25% |
| 2019 FY | -15.68 Million USD | -494.47% |
| 2019 Q4 | -15.68 Million USD | 45.81% |
| 2019 Q3 | -28.93 Million USD | -610.56% |
| 2019 Q2 | -4.07 Million USD | 74.64% |
| 2019 Q1 | -16.05 Million USD | -503.97% |
| 2018 Q2 | 27.35 Million USD | 76.33% |
| 2018 Q1 | 15.51 Million USD | -39.94% |
| 2018 FY | 3.97 Million USD | -84.61% |
| 2018 Q4 | 3.97 Million USD | 175.89% |
| 2018 Q3 | -5.23 Million USD | -119.15% |
| 2017 Q3 | 13.99 Million USD | 53.39% |
| 2017 Q2 | 9.12 Million USD | 118.92% |
| 2017 FY | 25.82 Million USD | 208.27% |
| 2017 Q1 | -48.23 Million USD | -102.2% |
| 2017 Q4 | 25.82 Million USD | 84.53% |
| 2016 Q3 | -24.32 Million USD | -12.01% |
| 2016 FY | -23.85 Million USD | 28.13% |
| 2016 Q1 | -29.12 Million USD | 12.26% |
| 2016 Q4 | -23.85 Million USD | 1.95% |
| 2016 Q2 | -21.71 Million USD | 25.42% |
| 2015 Q4 | -33.18 Million USD | 25.2% |
| 2015 Q3 | -44.36 Million USD | 48.35% |
| 2015 Q2 | -85.9 Million USD | -47.36% |
| 2015 Q1 | -58.29 Million USD | 22.57% |
| 2015 FY | -33.18 Million USD | 55.91% |
| 2014 FY | -75.28 Million USD | -17.34% |
| 2014 Q4 | -75.28 Million USD | -42.37% |
| 2014 Q3 | -52.87 Million USD | 7.67% |
| 2014 Q2 | -57.26 Million USD | 20.12% |
| 2014 Q1 | -71.69 Million USD | -11.75% |
| 2013 Q3 | -50.55 Million USD | 19.95% |
| 2013 Q4 | -64.15 Million USD | -26.89% |
| 2013 FY | -64.15 Million USD | 6.95% |
| 2013 Q1 | -54.72 Million USD | 20.63% |
| 2013 Q2 | -63.16 Million USD | -15.41% |
| 2012 Q2 | -55.59 Million USD | -15.22% |
| 2012 Q3 | -53.17 Million USD | 4.36% |
| 2012 Q4 | -68.94 Million USD | -29.66% |
| 2012 FY | -68.94 Million USD | -78.44% |
| 2012 Q1 | -48.25 Million USD | -24.89% |
| 2011 Q1 | -36.69 Million USD | 7.56% |
| 2011 Q2 | -35.49 Million USD | 3.25% |
| 2011 Q3 | -27.12 Million USD | 23.58% |
| 2011 FY | -38.63 Million USD | 2.65% |
| 2011 Q4 | -38.63 Million USD | -42.43% |
| 2010 Q3 | -26.1 Million USD | 25.33% |
| 2010 Q2 | -34.96 Million USD | -22.06% |
| 2010 Q1 | -28.64 Million USD | 8.48% |
| 2010 Q4 | -39.69 Million USD | -52.02% |
| 2010 FY | -39.69 Million USD | -26.81% |
| 2009 Q2 | -24.53 Million USD | 44.83% |
| 2009 Q1 | -44.47 Million USD | -18.6% |
| 2009 FY | -31.3 Million USD | 16.53% |
| 2009 Q4 | -31.3 Million USD | 16.39% |
| 2009 Q3 | -37.43 Million USD | -52.56% |
| 2008 Q1 | -96.95 Million USD | -4.86% |
| 2008 Q4 | -37.5 Million USD | 59.92% |
| 2008 Q2 | -90.74 Million USD | 6.4% |
| 2008 Q3 | -93.57 Million USD | -3.11% |
| 2008 FY | -37.5 Million USD | 59.44% |
| 2007 FY | -92.46 Million USD | -26.66% |
| 2007 Q4 | -92.46 Million USD | -7.46% |
| 2007 Q3 | -86.04 Million USD | -17.15% |
| 2007 Q2 | -73.45 Million USD | 7.02% |
| 2007 Q1 | -78.99 Million USD | -8.22% |
| 2006 FY | -72.99 Million USD | 19.79% |
| 2006 Q4 | -72.99 Million USD | 4.45% |
| 2006 Q2 | -92.31 Million USD | 5.21% |
| 2006 Q1 | -97.39 Million USD | -7.02% |
| 2006 Q3 | -76.39 Million USD | 17.24% |
| 2005 Q1 | -85.91 Million USD | -14.78% |
| 2005 FY | -91 Million USD | -21.59% |
| 2005 Q2 | -82.53 Million USD | 3.93% |
| 2005 Q3 | -91.7 Million USD | -11.11% |
| 2005 Q4 | -91 Million USD | 0.76% |
| 2004 FY | -74.84 Million USD | -16.62% |
| 2004 Q2 | -74.72 Million USD | -10.96% |
| 2004 Q4 | -74.84 Million USD | -5.14% |
| 2004 Q3 | -71.19 Million USD | 4.73% |
| 2004 Q1 | -67.34 Million USD | -4.93% |
| 2003 Q4 | -64.18 Million USD | -9.39% |
| 2003 Q3 | -58.67 Million USD | -0.49% |
| 2003 Q2 | -58.38 Million USD | -21.38% |
| 2003 Q1 | -48.1 Million USD | 0.45% |
| 2003 FY | -64.18 Million USD | -32.82% |
| 2002 Q3 | -42.29 Million USD | -10.31% |
| 2002 Q4 | -48.32 Million USD | -14.25% |
| 2002 FY | -48.32 Million USD | -41.04% |
| 2002 Q1 | -33.47 Million USD | 2.28% |
| 2002 Q2 | -38.33 Million USD | -14.52% |
| 2001 Q1 | -21.41 Million USD | 6.23% |
| 2001 FY | -34.25 Million USD | -49.99% |
| 2001 Q4 | -34.25 Million USD | -33.36% |
| 2001 Q3 | -25.69 Million USD | 3.31% |
| 2001 Q2 | -26.56 Million USD | -24.05% |
| 2000 Q4 | -22.84 Million USD | -34.63% |
| 2000 FY | -22.84 Million USD | -32.8% |
| 2000 Q1 | -13.53 Million USD | 21.29% |
| 2000 Q2 | -18.11 Million USD | -33.84% |
| 2000 Q3 | -16.96 Million USD | 6.36% |
| 1999 Q1 | -18.8 Million USD | -9.3% |
| 1999 Q2 | -14.2 Million USD | 24.47% |
| 1999 FY | -17.2 Million USD | 0.0% |
| 1999 Q3 | -12.7 Million USD | 10.56% |
| 1999 Q4 | -17.2 Million USD | -35.43% |
| 1998 FY | -17.2 Million USD | 3.37% |
| 1998 Q4 | -17.2 Million USD | 22.87% |
| 1998 Q3 | -22.3 Million USD | -52.74% |
| 1998 Q2 | -14.6 Million USD | 25.89% |
| 1998 Q1 | -19.7 Million USD | -10.67% |
| 1997 Q3 | -19.4 Million USD | -32.88% |
| 1997 Q1 | -23.2 Million USD | -2.2% |
| 1997 FY | -17.8 Million USD | 21.59% |
| 1997 Q2 | -14.6 Million USD | 37.07% |
| 1997 Q4 | -17.8 Million USD | 8.25% |
| 1996 Q1 | -17.3 Million USD | -6.13% |
| 1996 Q4 | -22.7 Million USD | -4.13% |
| 1996 FY | -22.7 Million USD | -39.26% |
| 1996 Q3 | -21.8 Million USD | -27.49% |
| 1996 Q2 | -17.1 Million USD | 1.16% |
| 1995 Q2 | -14 Million USD | -14.75% |
| 1995 Q4 | -16.3 Million USD | -11.64% |
| 1995 Q3 | -14.6 Million USD | -4.29% |
| 1995 Q1 | -12.2 Million USD | -8.93% |
| 1995 FY | -16.3 Million USD | -45.54% |
| 1994 FY | -11.2 Million USD | -41.77% |
| 1994 Q2 | -6.7 Million USD | 1.47% |
| 1994 Q3 | -10.4 Million USD | -55.22% |
| 1994 Q4 | -11.2 Million USD | -7.69% |
| 1994 Q1 | -6.8 Million USD | 13.92% |
| 1993 Q2 | -8.8 Million USD | -72.55% |
| 1993 Q1 | -5.1 Million USD | 20.31% |
| 1993 Q3 | -7.7 Million USD | 12.5% |
| 1993 Q4 | -7.9 Million USD | -2.6% |
| 1993 FY | -7.9 Million USD | -23.44% |
| 1992 Q2 | -7.4 Million USD | 2.63% |
| 1992 FY | -6.4 Million USD | 34.69% |
| 1992 Q1 | -7.6 Million USD | 22.45% |
| 1992 Q4 | -6.4 Million USD | -1.59% |
| 1992 Q3 | -6.3 Million USD | 14.86% |
| 1991 Q2 | -6.7 Million USD | 30.93% |
| 1991 FY | -9.8 Million USD | -34.25% |
| 1991 Q4 | -9.8 Million USD | -36.11% |
| 1991 Q3 | -7.2 Million USD | -7.46% |
| 1991 Q1 | -9.7 Million USD | -32.88% |
| 1990 Q4 | -7.3 Million USD | 56.29% |
| 1990 Q2 | -1.9 Million USD | -125.0% |
| 1990 Q1 | 7.6 Million USD | 24.59% |
| 1990 Q3 | -16.7 Million USD | -778.95% |
| 1990 FY | -7.3 Million USD | -219.67% |
| 1989 FY | 6.1 Million USD | 74.29% |
| 1989 Q4 | 6.1 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 1.41 Billion USD | 100.758% |
| Addus HomeCare Corporation | 110.39 Million USD | 109.688% |
| AirSculpt Technologies, Inc. | 89.4 Million USD | 111.962% |
| Amedisys, Inc. | 341.35 Million USD | 103.133% |
| Astrana Health, Inc. | 27.2 Million USD | 139.31% |
| Aveanna Healthcare Holdings Inc. | 1.45 Billion USD | 100.735% |
| IMAC Holdings, Inc. | -221.51 Thousand USD | -4728.203% |
| biote Corp. | 25.86 Million USD | 141.343% |
| Cryo-Cell International, Inc. | 10.48 Million USD | 201.955% |
| Cross Country Healthcare, Inc. | -11.82 Million USD | 9.571% |
| COMPASS Pathways plc | -187.58 Million USD | 94.299% |
| DocGo Inc. | -12.78 Million USD | 16.373% |
| The Ensign Group, Inc. | 1.36 Billion USD | 100.785% |
| InnovAge Holding Corp. | 56.08 Million USD | 119.068% |
| The Joint Corp. | -2.47 Million USD | -331.344% |
| LifeStance Health Group, Inc. | 432.21 Million USD | 102.474% |
| Mobile-health Network Solutions Class A Ordinary Shares | -6.05 Million USD | -76.76% |
| ModivCare Inc. | 1.13 Billion USD | 100.94% |
| NewGenIvf Group Limited | 278.44 Thousand USD | 3940.919% |
| Option Care Health, Inc. | 822.56 Million USD | 101.3% |
| P3 Health Partners Inc. | 83.7 Million USD | 112.777% |
| P3 Health Partners Inc. | 83.7 Million USD | 112.777% |
| The Pennant Group, Inc. | 323.57 Million USD | 103.305% |
| Surgery Partners, Inc. | 2.86 Billion USD | 100.373% |
| Syra Health Corp. Class A Common Stock | -3.03 Million USD | -252.741% |
| Talkspace, Inc. | -123.9 Million USD | 91.369% |
| Talkspace, Inc. | -123.9 Million USD | 91.369% |
| The Oncology Institute, Inc. | 86.32 Million USD | 112.389% |
| The Oncology Institute, Inc. | 86.32 Million USD | 112.389% |